Entering text into the input field will update the search result below

Healthcare ratings roundup - new coverage

Sep. 30, 2016 7:54 AM ETZoetis Inc. (ZTS) StockSNY, ARIA, DXCM, LCTX, ZTS, ALDX, AKBA, LNTH, VTVTBy: Douglas W. House, SA News Editor
  • Zoetis (NYSE:ZTS) initiated wit Buy rating with a $60 (18% upside) price target by Bank of America.
  • Akebia Therapeutics (NASDAQ:AKBA) initiated with Buy rating and $18 (106% upside) price target by Brean Capital.
  • DexCom (NASDAQ:DXCM) initiated with Neutral rating and $97 (10% upside) price target by B. Riley.
  • vtv Therapeutics (NASDAQ:VTVT) initiated with Buy rating and $13 (82% upside) price target by H.C. Wainwright.
  • ARIAD Pharmaceuticals (NASDAQ:ARIA) initiated with Outperform rating by Leerink Swann.
  • Aldeyra Therapeutics (NASDAQ:ALDX) initiated with Buy rating and $18 (139% upside) price target by H.C. Wainwright.
  • Lantheus Holdings (NASDAQ:LNTH) initiated with Neutral rating and $8 (1% upside) price target by Credit Suisse.
  • BioTime (NYSEMKT:BTX) initiated with Buy rating and $6 (63% upside) price target by Ladenburg.
  • Sanofi (NASDAQ:SNY) initiated with Neutral rating by Piper Jaffray.

Recommended For You

More Trending News

About ZTS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ZTS--
Zoetis Inc.